IndraLab

Statements



reach
"Furthermore, YOD1 knockdown promoted cell migration and invasion, whereas YOD1 overexpression inhibited those processes (Fig. 2H)."

reach
"However, research on YOD1 in renal cancer is scarce, highlighting the need for investigations into its role and potential as a therapeutic target in this type of carcinoma.In this study, we first conducted an unbiased RNAi screen targeting OTU deubiquitinating enzymes, which revealed that YOD1 deficiency significantly enhances cell migration."